Editorial Citrulline, Viagra® and BiDil® – Bad Medicine “Pfizer will someday come out with a 5 milligram Viagra (Sildenafil) for
cardiovascular use,” I said in the summer of 2004 to Suzy Cohen, America’s
“Dear Pharmacist” columnist. Although she debated the long-term use of
Viagra with me, Suzy did agree that in the pharmaceutical world, the financial
returns from FDA approval and patenting of a new indication for a drug often
overcome less expensive alternatives with better thought-out science. The
same financial model applies in the dietary supplement industry – but more
Chronic pulmonary hypertension causes blood pressure to rise inside the
lungs, which can result in heart failure and death. Although expensive and
impractical for long-term use, the standard treatment for infants with chronic
pulmonary hypertension usually involves delivering inhaled nitric oxide,
which relaxes the blood vessels in the lungs. Recent studies have shown that
adults whose pulmonary hypertension is reduced with nitric oxide can often
achieve similar results with Viagra taken orally. A small but growing body of
preliminary studies have shown Viagra also works in babies.
Viagra appears to have been first used on three infants with pulmonary
hypertension in 2002, in India, amidst great controversy. The chemical
pathways are similar. Both work on a chemical messenger (cyclic GMP)
that causes smooth muscle to relax. Viagra is a specific phosphodiesterase-
5 (PDE-5) inhibitor that works by slowing the natural breakdown of cyclic
GMP. This creates a higher level of cyclic GMP, with resultant smooth
muscle relaxation and vasodilation. While nitric oxide increases the amount
of cyclic GMP produced, Viagra keeps the chemical around longer.
The October 18, 2005, issue of the Journal of the American College of Cardiology reported that men with erectile dysfunction were more likely to
have the beginning signs of atherosclerosis – the clogging and hardening of
the arteries due to the buildup of plaque – than men without the disorder.
Men with erectile dysfunction had levels of C-reactive protein – a predictor
of future cardiovascular problems – that were more than twice as high as the
controls, as well as having impaired blood flow in the brachial artery.
The Italian researchers who conducted the study concluded erectile
dysfunction might be an independent and early warning sign of high risk for
coronary artery disease and cardiovascular problems. Perhaps I am missing
something here, but anyone that has even a passing interest in cardiovascular
Copyright 2005 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission. Alternative Medicine Review Volume 10, Number 4 December 2005
Editorial
disease figured out this connection long ago. You can just anticipate the
thought processes of the cardiologists, finding a new use for Viagra.
In addition to Viagra-linked deaths reported to FDA since its approval,
serious injuries have also been linked to Viagra use. Serious cardiovascular
conditions that have been linked to Viagra use include: heart attack, blood
clots, irregular heart rhythm, stroke, chest pain, blood pressure changes,
and sudden death. Side effects of Viagra may also lead to serious vision
problems. Viagra use has been linked to over 40 reports of a condition
called NAION (non-arteritic ischemic optic neuropathy), which can lead to
loss of vision and blindness. In the standard pharmaceutical model, let’s
If Pfizer follows the same financial model as Nitro Med, in attempting to
find new, patentable, limited uses for Viagra, they will be guilty of the same
disservice to good health that was described in my editorial about Nitro
Med, and their product BiDil, in Volume 10, Number 2. Marketing for the
sake of marketing when there are better choices available is not conducive to
the principle of choosing the path of least harm, not to mention cost.
Nitric oxide synthesis in vascular endothelial cells is a vital process for the
maintenance of vascular health. The amino acid L-arginine is the preferred
substance for oral supplementation to enhance nitric oxide synthesis.
The mechanism by which L-arginine works is by providing the substrate
for nitric oxide synthesis in vascular endothelial cells, which in turn creates
cyclic GMP in the underlying vascular smooth muscle cells. This is the
natural method, rather than slowing the breakdown of cyclic GMP with
Viagra, as discussed above. L-arginine works in vascular endothelial
cells throughout the body, whereas Viagra’s activity is more specific to
the penis. As stated above, Viagra is increasingly being used to treat
pulmonary hypertension and other cardiovascular conditions, although it
appears L-arginine provides equal or better results. For example, most
infants with pulmonary hypertension have an increased level of asymmetric
dimethylarginine (ADMA– an inhibitor of nitric oxide production) in their
blood. The easiest, most efficient method of combating this condition is
to supplement with L-arginine, which overcomes ADMA’s nitric oxide
Copyright 2005 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission. Alternative Medicine Review Volume 10, Number 4 December 2005
Editorial
Now, to the marketing end of the dietary supplement industry:
In the same footsteps of its big brother, the pharmaceutical industry, if there is
a market to be made for a product, sell it, even if there is more cost-effective
A prime example of this philosophy is the sales of glucosamine/chondroitin
combination products. Simply because of a popular book and a few studies
showing the combination of these two ingredients is helpful in the treatment
of joint conditions, the market has demanded this product. Companies have
added the product to their line simply to accommodate the demand of their
customers. I have told every doctor who mentions the words glucosamine or
chondroitin to purchase the less expensive glucosamine and save the patient
money. The individual ingredient, if made in a properly absorbable dosage
form, works equally as well as the combination of the two ingredients.
Utilizing the same model, some supplement companies are marketing L-
citrulline – a by-product of the arginine-to-nitric oxide pathway – as a
substance to increase nitric oxide synthesis in vascular endothelial cells.
Although safe, citrulline does not directly convert to nitric oxide, but instead
is recycled to L-arginine (an ATP-dependent process), which then converts
to nitric oxide. Ferid Murad, MD, PhD, Nobel-prize winner for his research
on nitric oxide, has said the use of L-citrulline to increase nitric oxide is only
marginally effective. However, ever in the spirit of making a silk purse out of
a sow’s ear, there will be created a market for this product, at a much greater
expense to the patient. As with chondroitin, the marketing machine is gearing
Common sense says toss out the Viagra, the BiDil and the citrulline, and
utilize L-arginine. Change bad medicine to good medicine and ignore the
Copyright 2005 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission. Alternative Medicine Review Volume 10, Number 4 December 2005
Gepubliceerd in Jurisprudentie Bestuursrecht 2012 - 280 ABRvS van 7 november 2012, LJN: BY2508, zaaknr. 201109485/1/A3 Art.: 3, 10, eerste lid, sub d, en tweede lid, sub e, Wob, 16 en 21, eerste lid, sub f, aanhef en onder 1, Wbp, 9, aanhef en onder a, Geneesmiddelenwet, 8:26 Awb Trefw.: handelsvergunning, bijwerking medicijnen, Risk Benefit Assessment van het MHRA, case reports,
Allied Academies International Conference THE INVESTORS ABILITY IN MAKING AN INVESTMENT DECISIONS ON THE GERMANY'S FINANCIAL MARKET-AN EMPIRICAL ANALYSIS Musa Darayseh, Purdue University Calumet Elaine Waples, Purdue University Calumet ABSTRACT Many U.S. companies and investors do business with German companies or own German subsidiaries. To comply with laws in both countrie